Performance funds/ETFs
BNP Paribas | BNP Health Care Innovators Acc
The fund invests at least 75% of its assets in equities and/or equity equivalent securities issued worldwide by health care companies that enable or benefit from innovative technologies, including, but not limited to, advances in genetic sequencing, drug delivery, miniaturization, bio-compatible materials, haptics and information technology to the healthcare field.
Growth in fund currency
Available documents (NL)
Available documents (EN)
Available documents for this product 
Quote
Quote
€365,95
Quote date
31-03-2026
Performance in EUR
Date
31-03-2026
This year
-6,12%
1 week
2,57%
1 month
-4,15%
3 months
-6,12%
6 months
7,48%
1 year
1,28%
3 years (annualised)
4,60%
5 years (annualised)
5,46%
Since start (annualised)
10,43%
Indicators
Standard deviation (3yr)
14,00%
Share ratio (3yr)
0,14
Beta (3yr)
1,07
Alpha (3yr)
0,51
Tracking error (3yr)
5,74
Top 10 holdings (28-02-2026)
Eli Lilly and Co
9,65 %
AstraZeneca PLC
8,19 %
Gilead Sciences Inc
5,03 %
Vertex Pharmaceuticals Inc
4,69 %
Intuitive Surgical Inc
4,64 %
Boston Scientific Corp
4,48 %
Jazz Pharmaceuticals PLC
4,01 %
AbbVie Inc
3,78 %
Thermo Fisher Scientific Inc
3,51 %
UCB SA
3,45 %
Fees
Entry fee
0,20%; free with Self Directed Investing Basic
Exit charges
0,20%; free with Self Directed Investing Basic
Estimated ongoing charges
1,07%
Dividend
Dividend paying
No
Characteristic
Asset Manager
BNP Paribas
Asset class
Equities
Investment category
Equities - Healthcare
Active/Passive
Active
Fund code
54248
Fund code fractional orders
54248
Fund manager name
Jon Stephenson|Christian Fay
ISIN
LU0823417224
Sustainable Classification
Art. 8, ESG integration
Sustainability Rating
Domicile
Luxembourg
Currency
EUR
Fund size (mio)
€1.570,10 (30-03-2026)
Cut-off time
15:30:00
Execution date
Yes, T+1
Inception date
17-05-2013
Benchmark
MSCI World/Health Care 10/40 NR EUR
Minimum investment amount
€20
Assortiment
Self Directed Investing Basic, Self Directed Investing Plus, Investment advice